Cargando…
Sierra SARS-CoV-2 sequence and antiviral resistance analysis program
INTRODUCTION: Although most laboratories are capable of employing established protocols to perform full-genome SARS-CoV-2 sequencing, many are unable to assess sequence quality, select appropriate mutation-detection thresholds, or report on the potential clinical significance of mutations in the tar...
Autores principales: | Tzou, Philip L., Tao, Kaiming, Sahoo, Malaya K., Kosakovsky Pond, Sergei L., Pinsky, Benjamin A., Shafer, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595491/ https://www.ncbi.nlm.nih.gov/pubmed/36334368 http://dx.doi.org/10.1016/j.jcv.2022.105323 |
Ejemplares similares
-
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
por: Tzou, Philip L., et al.
Publicado: (2022) -
Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
por: Tao, Kaiming, et al.
Publicado: (2022) -
The biological and clinical significance of emerging SARS-CoV-2 variants
por: Tao, Kaiming, et al.
Publicado: (2021) -
SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021) -
HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing
por: Tao, Kaiming, et al.
Publicado: (2023)